Any one work with colorspace data and have experience with Shrimp? I'm starting to work with such data and am exploring my options...
-
-
No, I think Shrimp is just too slow for the number of reads you get. I will try to do a comparison with ZOOM! and BFAST next week though, mainly for aligning reads that were discarded by corona. -
Thanks! This saves me time to figure out Shrimp... I look forward to your comparison between Zoom and Bfast.
I do something similar for Illumina - first Eland and then Bowtie...Comment
-
Chipper.. have you tried CLC Bio?Comment
-
How about MAQ?Comment
-
I hated Corona for my applications. I liked SHRiMP for shorter reads (25 nt) but it's too slow for longer reads. Currently testing ZOOM, which looks good. Interested in other suggestions within reasonable academic means....Comment
-
-
although MAQ is not truly designed to work with SOLiD data, so functions have been added to convert solid reads to fastqComment
-
(correct me if I'm wrong)
When colorspace data is converted to sequence, there is a significant loss of information... for example, single mismatch in colorspace may result in 2 mismatches in sequence.
So I think methods that work exclusively in colorspace are preferable.Comment
-
Align in colorspace
No doubt about it, alignment needs to be done in colorspace for SOLiD. Makes a significant difference in useable data.Comment
-
yeah.. that's interesting cuz I'm sure Heng know about this problem. Perhaps its just a quick hack for now.. and they'll have more in the pipeline.Comment
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...
Comment